We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.45 | 4.30 | 4.60 | 4.45 | 4.45 | 4.45 | 343,084 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.60 | 23.73M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/12/2023 16:04 | Investingisatrickyga 0 0 0 Brucie5 It seems to me you are making judgements today, based on the past, but the past is not where Eden is today. Review where we are today and make a judgement based on that. If we all based Eden on the past, we wouldn't be invested, would we! -------------------- Investing, call it a case of once; no, twice; no thrice bitten... As stated I have taken out a starter position once again. My last bite was at 3p, when unfortunately my nerv3es caught a chill and I exited prematurely just before it rose to 12p in June; only to slump again. I am giving them some benefit of the doubt on account of the cash runway and a certain amount of excitement over Ecovelex. Thus far, andn for time being, very little further, though of course, I am open to being pleasantly surprised should the proverbial leopard change its spots. | brucie5 | |
04/12/2023 16:01 | > Sales. And so far, against years of promises, it's next to nothing. …. I agree, sales for a number of years have been dire, no other word for it, but sales ‘21 to ‘22 were up 44.3% and are expected to be even higher ‘22 to ‘23 at> 55%. During 2023 Mevalone and Cedroz approved in the largest single market, the USA with California state approval of Mevalone expected any day now. Ecovelex approvals in EUA coming soon along with launch of new product with the insecticide. The tide has turned in my opinion. | kittybiscuits | |
04/12/2023 15:56 | Brucie5 I think you're being too harsh. Eden didn't have the regulatory footprint years ago, or the label extension opportunities. That has and is changing right now. They didn't have a global seed product back then; they do now and the recent online investor conference explained that when the current incumbent is soon removed, there is nothing to repel birds, save Ecovelex. This will deliver significant sales for Eden. Furthermore, why would one company spend a not insignificant sum trialling 140 locations for Eden's soon to be announced and contracted, global insecticide. Because they clearly believe that insecticide might/will work for them globally. It seems to me you are making judgements today, based on the past, but the past is not where Eden is today. Review where we are today and make a judgement based on that. If we all based Eden on the past, we wouldn't be invested, would we! | investingisatrickygame | |
04/12/2023 15:05 | Love your enthusiasm, Kitty, but repeat after me: What's it all about? Sales. And so far, against years of promises, it's next to nothing. | brucie5 | |
04/12/2023 14:55 | + The global biopesticides market is projected to be worth more than $11 billion by 2027 + 30% of active ingredients in the EU are at medium to high risk of failing to receive renewal of their regulatory authorisations (Due to chemical bans/microplastics etc) + 15%....the biopesticides market is growing at compounded annual growth rate of 15% Which company is now primed to take advantage of those numbers? I know! | kittybiscuits | |
04/12/2023 14:42 | Opportunity.. bigger than Cedroz and Mevalone combined. | supersonico | |
04/12/2023 14:41 | A global deal. | supersonico | |
04/12/2023 14:39 | A Dearth of bio insecticide product available .. so much interest in the product. | supersonico | |
04/12/2023 14:06 | Covert videos of Mock Auctions are available on Youtube. Anyone who doesn't understand the SCAM that is conducted on this bulletin board should watch a few of them. The technique is the same, variations are minor. This is also a BOILER ROOM. Operated by FILTH. | neutralpov | |
04/12/2023 12:44 | Investing, you wouldn't expect me to argue against what you wrote! | attyg | |
04/12/2023 12:33 | AttyG Alex also states that Ecovelex sales should hit peak sales 'in short order'. So as you rightly point out in various posts, Eden should move to profit quickly, 2024 in my opinion and the rise from €2 million- €100 million per annum could come quite quickly for Eden, given where we are today and accepting that 3-5 years ago we were not in a position anywhere as near as positive as now. | investingisatrickygame | |
04/12/2023 07:32 | At 13.10 on the 1 Dec Virtual Presentation Sean, talking of Californian approval for Mevalone says "... in the process of going through public consultation....and we expect that authoristation in very short order.." Public consultation: Difficult to think that is interviewing people on the street or asking members of the public to write in and approve or reject mevalone. I am thinking it must be making enquiries within the industry? Just my guess. If so, then I was lead to believe that the farmers etc are desperate for mevalone. Again - just my understanding. However, that understanding chimes with Sean saying - in very short order. I am sure Alex refers to Californian approval in similarly confident tones, later on this presentation. I conclude Eden continues to expect approval soon - if within the next, what, two weeks, then we may be able to ship the Sipcam order before the y/e. Just a thought. | attyg | |
03/12/2023 21:43 | Investingisatrickyga 0 0 1 Brucie5 The cash raise will last longer than a year. Where do you get one year from? -------------------- Think of a number; then halve it. ;) | brucie5 | |
03/12/2023 19:41 | The game dramatically changed in 2018 and those who think Eden are at the same point they were five years ago will shortly learn how very poorly they have informed themselves in the intervening years. | supersonico | |
03/12/2023 18:12 | Brucie, please do not take my comments as investment advice. Regarding capital destruction - I know all about that from having bought lots at much higher prices than 4p - though it can be said that a share price does not have much further to fall when it is at 4p. So, in my view, the downside is small and the upside is great. DYOR | attyg | |
03/12/2023 17:34 | Brucie5 The cash raise will last longer than a year. Where do you get one year from? | investingisatrickygame | |
03/12/2023 16:27 | AttyG3 Dec '23 - 15:31 - 15886 of 15887 -------------------- Good post, Atty; BUT you were saying similar about five years ago, as many were. Credibility of sales is now shot to pieces, so it matters little what projection sizes might suggest, if the material amounts continue to be miniscule. This needs to change. That said - yes, obviously I can see the story and that has given the bod many years of stringing investor interest along. Whatever happened to the back to school flea treatment, lols?! The fact that I now have a holding again is more to do with 1. the current discount to recent raise at 6.5p. 2. the fact that they did well to persuade another lot of investors to give them the necessary cash for another year. But it now needs to come good, so that the next raise, which there will quite inevitably be, will be at appreciably higher price. I don't mean to sound snide about you or other enthusiasts here - it's great that you're so positive and many of us learn from your research. But this share is - and always has been - very high risk for capital destruction. | brucie5 | |
03/12/2023 16:15 | “How quickly can Eden grow from £2m sales to £100m sales? Answer: They can do that in one year. When are they going to do that then? Answer: When they receive regulatory approval.“ Yes, this has been the sales pitch for the last 25 years The problem is that the regulatory approval always seems to need further approval, either not previously mentioned by the board, or else seeming to come as a complete surprise to them The EU regulatory approval received in 2014 does not seem to have moved matters forward one iota, despite all the trumpeting at the time | gemstar2 | |
03/12/2023 15:34 | Ha ha. Brilliant super - we're gonna need more dreams to spend all our money! | attyg | |
03/12/2023 14:05 | WARNING TO ANY POTENTIAL INVESTORS STRAYING INTO THIS THREAD. This thread is a BOILER ROOM SCAM. This "Research" (lol) share, note NOT a "Sales" share, is relentlessly ramped by a small gang of multi-avatar liars, PAID or desperate holders looking to engineer a way out. The only significant institutional is trying to get out too. THIS IS ONLY FOR THOSE WHO LIKE MAKING CHARITABLE CONTRIBUTIONS TO GREEDY A'WIPES.... | neutralpov |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions